Pfizer has agreed to hand over email chains between the drugmaker’s expert witness in the Zoloft multidistrict litigation and authors of studies on the risks of the antidepressant.
The company detailed Thursday its willingness to produce the documents in reply to the plaintiffs’ motion for expedited discovery, filed Tuesday. The plaintiffs’ motion came after the Daubert hearing in the case was pushed back to September. U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania rescheduled the hearing July 7 after a defense medical expert discovered alleged errors in an article about the drug’s risk of causing birth defects.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
